This time, our newsletter begins with an article signed by Rene van den Wijngaard about a new pilot randomized, doubled-blind, placebo-controlled trial that suggest the potential of spore-forming probiotics in patients with functional dyspepsia.
Next up, a new proof-of-principle study reveals that supplementing low-fermentable fiber following fecal microbiota transplantation may improve insulin sensitivity in individuals with severe obesity. You will also come across new proof-of-concept findings from INRAE suggesting that the combined targeting of host inflammation and the state of the gut microbiota could be an approach worth considering for increasing remission in patients with ulcerative colitis.
Finally, a new study shows that fermented-food diet may increase microbiome diversity and decrease markers of inflammation.
The GMFH publishing team